| 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving … V Strnad, OJ Ott, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ... The Lancet 387 (10015), 229-238, 2016 | 732* | 2016 |
| Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 E Fokas, M Allgäuer, B Polat, G Klautke, GG Grabenbauer, R Fietkau, ... Journal of Clinical Oncology 37 (34), 3212-3222, 2019 | 421 | 2019 |
| Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma M Fassnacht, S Hahner, B Polat, AC Koschker, W Kenn, M Flentje, ... The Journal of Clinical Endocrinology & Metabolism 91 (11), 4501-4504, 2006 | 301 | 2006 |
| Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery … C Polgár, OJ Ott, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ... The Lancet Oncology 18 (2), 259-268, 2017 | 271 | 2017 |
| 68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT C Bluemel, M Krebs, B Polat, F Linke, M Eiber, S Samnick, C Lapa, ... Clinical nuclear medicine 41 (7), 515-521, 2016 | 218 | 2016 |
| Radiotherapy in adrenocortical carcinoma B Polat, M Fassnacht, L Pfreundner, M Guckenberger, K Bratengeier, ... Cancer 115 (13), 2816-2823, 2009 | 218 | 2009 |
| Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO … E Fokas, A Schlenska-Lange, B Polat, G Klautke, GG Grabenbauer, ... JAMA oncology 8 (1), e215445-e215445, 2022 | 191 | 2022 |
| Dose–response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy M Guckenberger, K Baier, B Polat, A Richter, T Krieger, J Wilbert, ... Radiotherapy and Oncology 97 (1), 65-70, 2010 | 179 | 2010 |
| Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast … R Schäfer, V Strnad, C Polgár, W Uter, G Hildebrandt, OJ Ott, ... The lancet oncology 19 (6), 834-844, 2018 | 114 | 2018 |
| GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early … OJ Ott, V Strnad, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ... Radiotherapy and oncology 120 (1), 119-123, 2016 | 105 | 2016 |
| Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer M Guckenberger, S Ok, B Polat, RA Sweeney, M Flentje Strahlentherapie und Onkologie 10 (186), 535-543, 2010 | 104 | 2010 |
| A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy N Hardcastle, WA Tomé, DM Cannon, CL Brouwer, PWH Wittendorp, ... Radiation oncology 7, 1-7, 2012 | 97 | 2012 |
| Nonrigid patient setup errors in the head-and-neck region. B Polat, J Wilbert, K Baier, M Flentje, M Guckenberger Strahlentherapie und Onkologie 183 (9), 2007 | 94 | 2007 |
| Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer B Polat, I Guenther, J Wilbert, J Goebel, RA Sweeney, M Flentje, ... Strahlentherapie und Onkologie 184 (12), 668, 2008 | 91 | 2008 |
| Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings HD Hummel, P Kufer, C Grüllich, R Seggewiss-Bernhardt, ... Immunotherapy 13 (2), 125-141, 2021 | 90 | 2021 |
| Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: the SAKK 09/10 randomized phase 3 trial P Ghadjar, S Hayoz, J Bernhard, DR Zwahlen, T Hölscher, P Gut, B Polat, ... European urology 80 (3), 306-315, 2021 | 89 | 2021 |
| Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci CS Djuzenova, I Elsner, A Katzer, E Worschech, LV Distel, M Flentje, ... Radiation oncology 8, 1-12, 2013 | 89 | 2013 |
| Radiosensitization of glioblastoma cell lines by the dual PI3K and mTOR inhibitor NVP-BEZ235 depends on drug-irradiation schedule S Kuger, D Graus, R Brendtke, N Günther, A Katzer, P Lutyj, B Polat, ... Translational oncology 6 (2), 169-IN16, 2013 | 70 | 2013 |
| Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells C Shen, A Buck, B Polat, A Schmid-Kotsas, C Matuschek, HJ Gross, ... Cancer gene therapy 10 (5), 403-410, 2003 | 70 | 2003 |
| Novel PI3K and mTOR inhibitor NVP-BEZ235 radiosensitizes breast cancer cell lines under normoxic and hypoxic conditions S Kuger, E Cörek, B Polat, U Kämmerer, M Flentje, CS Djuzenova Breast Cancer: Basic and Clinical Research 8, BCBCR. S13693, 2014 | 68 | 2014 |
Martin FassnachtUniversitätsklinikum Würzburg在 medizin.uni-wuerzburg.de 的电子邮件经过验证
